Barrier dysfunction in the atopic march—how does atopic dermatitis lead to asthma in children? - 08/06/20
Doi : 10.1016/j.jaci.2020.04.014
Kenji Matsumoto, MD, PhD a, ⁎ 
, Katsuhito Iikura, MD, PhD b, Hideaki Morita, MD, PhD a, Hirohisa Saito, MD, PhD a
, Katsuhito Iikura, MD, PhD b, Hideaki Morita, MD, PhD a, Hirohisa Saito, MD, PhD a a Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan
b Department of Pediatrics, National Hospital Organization Nishisaitama-chuo National Hospital, Saitama, Japan
∗Corresponding author: Kenji Matsumoto, MD, PhD, Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo 157-8535, Japan.Department of Allergy and Clinical ImmunologyNational Research Institute for Child Health and Development2-10-1OkuraSetagaya-kuTokyo157-8535Japan
Key words : Atopic dermatitis, asthma, antiviral IFNs, atopic march
Le texte complet de cet article est disponible en PDF.
| This work was supported in part by a grant from the National Center for Child Health and Development, Japan (grant no. 2020B-4 to K.M.). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 145 - N° 6
P. 1551-1553 - juin 2020 Retour au numéro
Article précédent
- News Beyond Our Pages
- Marc E. Rothenberg, Jean Bousquet
- IgE to cross-reactive carbohydrate determinants: Origins, functions, and confounding role in nPhl p 4-IgE assays
- Paolo Maria Matricardi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?